EcoDrugPlus

Amyloid P Component, Serum

Ensembl ID : ENSMSIG00000032017
Gene Symbol: APCS
1 Cross references
455 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein

Ensembl ID : ENSMSIG00000000483
Gene Symbol: APP
1 Cross references
291 Possible Orthologues:

Angiotensin I Converting Enzyme (Peptidyl-Dipeptidase A) 1

Ensembl ID : ENSMSIG00000025422
Gene Symbol: ACE
1 Cross references
108 Possible Orthologues:

Angiotensin Ii Receptor, Type 1a

Ensembl ID : ENSMSIG00000003511
Gene Symbol: AGTR1A
1 Cross references
195 Possible Orthologues:

Angiotensin Ii Receptor, Type 1b

Ensembl ID : ENSMSIG00000002747
Gene Symbol: AGTR1B
1 Cross references
210 Possible Orthologues:

Angiotensin Ii Receptor, Type 2

Ensembl ID : ENSMSIG00000002524
Gene Symbol: AGTR2
1 Cross references
206 Possible Orthologues:

Apelin Receptor

Ensembl ID : ENSMSIG00000001760
Gene Symbol: APLNR
1 Cross references
186 Possible Orthologues:

Aph1 Homolog C, Gamma Secretase Subunit

Ensembl ID : ENSMSIG00000022355
Gene Symbol: APH1C
1 Cross references
195 Possible Orthologues:

Apurinic/apyrimidinic Endonuclease 1

Ensembl ID : ENSMSIG00000019485
Gene Symbol: APEX1
1 Cross references
227 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSMSIG00000020125
Gene Symbol: ALOX12
1 Cross references
215 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSMSIG00000002190
Gene Symbol: ALOX5
1 Cross references
235 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSMSIG00000023243
Gene Symbol: ALOX5AP
1 Cross references
215 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).